Ultrahypofractionated radiotherapy better preserves B- and T-cell immunity than conventional fractionated radiotherapy in prostate cancer.
Journal: Journal of translational medicine
•
Abstract
Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.
Subjects & Keywords
How to Cite this Article
Rosado MM, Palermo B, Bottero M, et al. (2026). "Ultrahypofractionated radiotherapy better preserves B- and T-cell immunity than conventional fractionated radiotherapy in prostate cancer.". Journal of translational medicine. https://doi.org/10.1186/s12967-026-08773-z